January 9, 2026
0
Answer Awaiting
Q.1 Regulatory flexibility in the pharmaceutical sector must not come at the cost of public health safeguards. Discuss this statement in the context of recent relaxations issued by the Central Drugs Standard Control Organization. (10 Marks, 150 Words)
Paper:
Subject:

GS Foundation
Optional Course
Combo Courses
Degree Program
